Comparative impact of scintigraphic parameters and B-type natriuretic peptide for the prediction of major cardiac events in the QGS-prognostic value in the elderly (Q-PROVE) study

Circulation Journal

Volumn 73, Issue 9, 2009, Pages 1655-1660

  Igarashi, Yuko ^a   Chikamori, Taishiro ^a   Hida, Satoshi ^a   Nagao, Tadashi ^a   Tanaka, Hirokazu ^a   Usui, Yasuhiro ^a   Hatano, Tsuguhisa ^a   Morishima, Takayuki ^a   Yanagisawa, Hidefumi ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

B type natriuretic peptide; Coronary artery disease; Elderly; Single photon emission computed tomography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; AGING; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; EVENT FREE SURVIVAL; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; SCINTIGRAPHY; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; VOLUMETRY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; UP-REGULATION;

EID: 69549109779     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0146     Document Type: Article

References (30)

1. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352: 666-675. (Pubitemid 40239214)
2. Domingo KB, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: Data from the Heart and Soul Study. Circulation 2003; 108: 2987-2992. (Pubitemid 37553567)
3. OmLand T, Richards AM, Wergeland R, Vik-Mo H. B-Type natriuretic peptide and long-term survival in patients with stable coronary artery disease. Am J Cardiol 2005; 95: 24-28. (Pubitemid 40051107)
4. Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, for the Christchurch Cardioendocrine Research Group and the Australia-New Zealand Heart Failure Group. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 2006; 47: 52-60.
5. 99mTc sestamibi predicts major cardiac events in elderly patients with known or suspected coronary artery disease. Circ J 2007; 71: 1029-1034.
6. Hida S, Chikamori T, Usui Y, Yanagisawa H, Morishima T, Yamashina A, et al. Effect of percutaneous coronary angioplasty on myocardial perfusion, function, and wall thickness as assessed by quantitative gated single-photon emission computed tomography. Am J Cardiol 2003; 91: 591-594. (Pubitemid 36263263)
7. Tanaka H, Chikamori T, Hida S, Usui Y, Harafuji K, Igarashi Y, et al. Comparison of post-exercise and post-vasodilator stress myocardial stunning as assessed by electrocardiogram-gated single-photon emission computed tomography. Circ J 2005; 69: 1338-1345. (Pubitemid 41560812)
8. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FD, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 639-647.
9. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
10. Nakajima K, Kusuoka H, Nishimura S, Yamashina A, Nishimura T. Normal limits of ejection fraction and volumes determined by gated SPECT in clinically normal patients without cardiac events: A study based on the J-ACCESS database. Eur J Nucl Med 2007; 34: 1088-1096. (Pubitemid 46919549)
11. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of hear failure. Eur Heart J 1995; 16: 741-751.
12. Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin MD, et al. Diagnosing and managing unstable angina. Circulation 1994; 90: 613-622.
13. Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: Results from the AtheroGene study. J Am Coll Cardiol 2006; 47: 552-558. (Pubitemid 43170843)
14. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PH, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1349-1353.
15. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Due P, et al. Breathing Not Properly multinational study investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
16. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003; 42: 728-735. (Pubitemid 37000195)
17. Mueller C, Scholer A, Laule-Kilian K, Benedict Martina BC, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647-654. (Pubitemid 38364623)
18. Takahashi N, Yamamoto A, Tezuka S, Ishikawa M, Abe J, Aminani K, et al. Assessment of left ventricular dyssynchrony during development of heart failure by a novel program using ECG-gated myocardial perfusion SPECT. Circ J 2008; 72: 370-377. (Pubitemid 351600628)
19. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000; 101: 1465-1478. (Pubitemid 30169872)
20. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC Guidelines for the clinical use of cardiac radionuclide imaging. JAm Coll Cardiol 2003; 42: 1318-1333.
21. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: Risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001; 42: 831-837. (Pubitemid 32537427)
22. Valeti US, Miller TD, Hodge DO, Gibbons RJ. Exercise single-photon emission computed tomography provides effective risk stratification of elderly men and elderly women. Circulation 2005; 111: 1771-1776.
23. Kawamura M, Ohta Y, Katoh K, Nishimura S. Medium- to long-term prognostic impact of dipyridamole thallium-201 myocardial single-photon emission computed tomography in elderly patients. Circ J 2003; 67: 913-917. (Pubitemid 37370239)
24. Winter OD, Velghe A, de Veire NV, Bondt PD, Buyzere MD, De Wiele CV, et al. Incremental prognostic value of combined perfusion and function assessment during myocardial gated SPECT in patients aged 75 years or older. J Nucl Cardiol 2005; 12: 662-670. (Pubitemid 43033606)
25. Kusuoka H, Nishimura S, Yamashina A, Nakajima K, Nishimura T, for the J-ACCESS investigators. Surveillance study for creating the national clinical database related to ECG-gated myocardial perfusion SPECT of ischemic heart disease: J-ACCESS study design. Ann Nucl Med 2006; 20: 195-202.
26. Ishino M, Takeishi Y, Niizeki T, Watanabe T, Nitobe J, Miyamoto T, et al. Risk stratification of chronic heart failure patients by multiple biomarkers. Circ J 2008; 72: 1800-1805.
27. Groenning BA, Nilsson JC, Sondergaard L, Pedersen F, Trawinski J, Baumann M, et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 2002; 143: 923-929. (Pubitemid 34595355)
28. Eggers KM, Lindahl B, Venge P, Lind L. B-type natriuretic peptides and their relation to cardiovasucular structure and function in a population-based sample of subjects. Am J Cardiol 2009; 103: 1032-1038.
29. Foote RS, Pearlman JD, Siegel AH, Yeo KT. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 2004; 474: 1980-1987.
30. Sabatine MS, Morrow DA, de Lemos JA, OmLand T, Desai MY, Tanasijevic M, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004; 44: 1988-1995. (Pubitemid 39473283)